Dabrafenib Mesylate and UTA Capsules
Determining the interaction of Dabrafenib Mesylate and UTA Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate
Brand name: Urogesic-Blue, UTA, Uro-BLUE, Urolet MB, Indiomin MB, ME/NaPhos/MB/Hyo1, UTA
Synonyms: Hyoscyamine, methenamine, methylene blue, and sodium biphosphate, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-UTAC tablets
- Dabrafenib Mesylate-UTI Relief
- Dabrafenib Mesylate-Utibron Neohaler
- Dabrafenib Mesylate-Uticap
- Dabrafenib Mesylate-Utira-C
- Dabrafenib Mesylate-Utira-C Tablets
- UTA Capsules-Dacarbazine
- UTA Capsules-Dacarbazine Intravenous, Injection
- UTA Capsules-Daclatasvir
- UTA Capsules-Daclatasvir Dihydrochloride
- UTA Capsules-Daclizumab
- UTA Capsules-Daclizumab Subcutaneous